Skip to content
← All startups
Octave Bioscience logo

Octave Bioscience

Series C

Provider of AI-based molecular diagnostic tools for neurodegenerative diseases. The company has developed the first blood test to measure disease activity at the biology level. The platform will captures data using sensors, wearables & mobile tools to identify changes in disease status and optimize images adding quantitation, serial trends.

Life Sciences · Neurology · Menlo Park, United States · EST 2014

About

Provider of AI-based molecular diagnostic tools for neurodegenerative diseases. The company has developed the first blood test to measure disease activity at the biology level. The platform will captures data using sensors, wearables & mobile tools to identify changes in disease status and optimize images adding quantitation, serial trends.

Institutional investors

NovartisIntermountain VenturesBVFEcho Health VenturesNorthpond VenturesDeerfieldCasdin CapitalMerckHikma VenturesS32The Michael J. Fox FoundationMerck Global Health Innovation Fund

Latest coverage

📰 See all funding news — keep up with the raises that set comps.

Investor directory

🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.

Raising like Octave Bioscience?

Analyze your pitch deck before your next raise.

Analyze My Deck →